BPC-157 is not an FDA-approved retail drug, but it is legally obtainable in the United States through a licensed compounding pharmacy when prescribed by a medical provider after a clinical evaluation
Thymosin beta-4 peptides have been examined for their effects on inflammatory signaling networks and cellular survival pathways, with studies describing modulation of endothelial behavior, oxidative stress responses, and reparative cell activity in experimental models [7][8]
It is a prescribed compounded medication that needs a provider intake, dose titration, and follow-up, exactly like any other clinical prescription
Note the safety label: pharmaceutical bacteriostatic water carries a warning against use in newborns because of the benzyl alcohol
in fact, their weight reduction was less pronounced than that of those on the lower dose